Drugs Made In America Acquisition (DMAA) vs Inflection Point Acquisition VIII (IPHX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Drugs Made In America Acquisition is the larger company by market cap ($263.4 million vs $247.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DMAA | IPHX |
|---|---|---|
| Share price | $10.85 | $9.90 |
| Market cap | $263.40M | $247.50M |
| 1-day change | +0.18% | 0.00% |
| P/E ratio (TTM) | 60.28 | — |
| EPS (TTM) | $0.18 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.89 | $10.00 |
| 52-week low | $10.26 | $9.42 |
| Distance from 52-week high | -0.37% | -1.00% |
| Average volume | 21.64K | 24.23K |
| Shares outstanding | 24.28M | 25.00M |
| Sector | Financial Services | Financial Services |
| Industry | Shell Companies | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Drugs Made In America Acquisition
DMAA stock →Drugs Made In America Acquisition Corp. does not have significant operations.
Financial Services · Shell Companies
About Inflection Point Acquisition VIII
IPHX stock →Inflection Point Acquisition Corp. VIII focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Financial Services · Shell Companies
DMAA vs IPHX FAQ
Which is bigger, Drugs Made In America Acquisition or Inflection Point Acquisition VIII?
Drugs Made In America Acquisition (DMAA) is larger, with a market capitalization of $263.40M compared with $247.50M for Inflection Point Acquisition VIII (IPHX).
Are Drugs Made In America Acquisition and Inflection Point Acquisition VIII in the same industry?
Yes. Both are classified in the Shell Companies industry within the Financial Services sector.